Madrigal Pharmaceuticals, Inc. (MDGL)

434.24 -19.10 (-4.21%) USD  |  NASDAQ  |  Oct 23, 16:00
437.68 +3.44 (+0.79%) After-Hours: 20:00
More

Madrigal Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to . Start Trial.
Date Value

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. --
Cytokinetics, Inc. Upgrade
Insmed, Inc. --
United Therapeutics Corp. Upgrade
Karyopharm Therapeutics, Inc. --